110 related articles for article (PubMed ID: 1362406)
1. A preliminary analysis of consortium data for markers tightly linked to multiple endocrine neoplasia type 2A.
Lichter JB; Hackleman SM; Ponder BA; Easton D; Narod SA; Lenoir GM; Gagel RF; Simpson NE; Gardner E; Goodfellow PJ
Henry Ford Hosp Med J; 1992; 40(3-4):205-9. PubMed ID: 1362406
[TBL] [Abstract][Full Text] [Related]
2. Closing in on the MEN2A locus.
Simpson NE; Kidd KK
Henry Ford Hosp Med J; 1989; 37(3-4):100-5. PubMed ID: 2576936
[TBL] [Abstract][Full Text] [Related]
3. The mapping of the locus for multiple endocrine neoplasia type 2A by linkage with chromosome 10 markers.
Simpson NE; Kidd KK
Horm Metab Res Suppl; 1989; 21():5-9. PubMed ID: 2572529
[TBL] [Abstract][Full Text] [Related]
4. Progress toward resolving the possible linkage of multiple endocrine neoplasia type 2A to haptoglobin and group-specific loci: use of restriction fragment length polymorphisms extends exclusion region.
Kidd KK; Kidd JR; Castiglione CM; Pakstis AJ; Sparkes RS
Genet Epidemiol; 1986; 3(3):195-200. PubMed ID: 2873080
[TBL] [Abstract][Full Text] [Related]
5. One large kindred excludes a locus for multiple endocrine neoplasia type 2A from about 25% of the human autosomal genetic map.
Pakstis AJ; Kidd JR; Castiglione CM; Pletcher BA; Murphy PD; Farrer LA; Genel M; Kidd KK
Henry Ford Hosp Med J; 1987; 35(2-3):164-7. PubMed ID: 2891651
[No Abstract] [Full Text] [Related]
6. Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A.
Lairmore TC; Howe JR; Korte JA; Dilley WG; Aine L; Aine E; Wells SA; Donis-Keller H
Genomics; 1991 Jan; 9(1):181-92. PubMed ID: 1672289
[TBL] [Abstract][Full Text] [Related]
7. Localization of the gene for MEN 2A.
Lichter JB; Difilippantonio M; Wu J; Miller D; Ward DC; Goodfellow PJ; Kidd KK
Henry Ford Hosp Med J; 1992; 40(3-4):199-204. PubMed ID: 1362405
[TBL] [Abstract][Full Text] [Related]
8. Screening for multiple endocrine neoplasia type 2A with DNA-polymorphism analysis.
Lamothe EM; Narod SA; Miller S; Goodfellow PJ; Cole DE; Gilchrist D; Pausova Z; Goltzman D; Hendy GN
Henry Ford Hosp Med J; 1992; 40(3-4):224-6. PubMed ID: 1362410
[TBL] [Abstract][Full Text] [Related]
9. Genetics of the multiple endocrine neoplasia type 2B syndrome.
Jackson CE; Norum RA
Henry Ford Hosp Med J; 1992; 40(3-4):232-5. PubMed ID: 1362412
[TBL] [Abstract][Full Text] [Related]
10. Linked markers flanking the gene for multiple endocrine neoplasia type 2A.
Nakamura Y; Mathew CG; Sobol H; Easton DF; Telenius H; Bragg T; Chin K; Clark J; Jones C; Lenoir GM
Genomics; 1989 Aug; 5(2):199-203. PubMed ID: 2571570
[TBL] [Abstract][Full Text] [Related]
11. Where is the locus for multiple endocrine neoplasia type 2A?
Simpson NE; Kidd KK
Henry Ford Hosp Med J; 1987; 35(2-3):168-71. PubMed ID: 2891652
[No Abstract] [Full Text] [Related]
12. Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage.
Simpson NE; Kidd KK; Goodfellow PJ; McDermid H; Myers S; Kidd JR; Jackson CE; Duncan AM; Farrer LA; Brasch K
Nature; 1987 Aug 6-12; 328(6130):528-30. PubMed ID: 2886918
[TBL] [Abstract][Full Text] [Related]
13. Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms.
Larsson C; Shepherd J; Nakamura Y; Blomberg C; Weber G; Werelius B; Hayward N; Teh B; Tokino T; Seizinger B
J Clin Invest; 1992 Apr; 89(4):1344-9. PubMed ID: 1348254
[TBL] [Abstract][Full Text] [Related]
14. An efficient strategy for gene mapping using multipoint linkage analysis: exclusion of the multiple endocrine neoplasia 2A (MEN2A) locus from chromosome 13.
Farrer LA; Goodfellow PJ; Lamarche CM; Franjkovic I; Myers S; White BN; Holden JJ; Kidd JR; Simpson NE; Kidd KK
Am J Hum Genet; 1987 Apr; 40(4):329-37. PubMed ID: 2883889
[TBL] [Abstract][Full Text] [Related]
15. Studies of multiple endocrine neoplasia type 2A syndrome: linkage analyses and comparison of constitutional and tumor genotypes.
Tateishi H; Takai S; Nishisho I; Miki T; Motomura K; Okazaki M; Miyauchi A; Ikeuchi T; Yamamoto K; Hattori T
Henry Ford Hosp Med J; 1987; 35(2-3):157-60. PubMed ID: 2891649
[No Abstract] [Full Text] [Related]
16. Presymptomatic identification of carriers of the multiple endocrine neoplasia type 2A gene using flanking DNA markers.
Howe JR; Lairmore TC; Dou S; Mishra SK; Dilley WG; Donis-Keller H; Wells SA
Surgery; 1992 Aug; 112(2):219-25; discussion 225-6. PubMed ID: 1353639
[TBL] [Abstract][Full Text] [Related]
17. Genetic mechanisms of neoplasia in MEN 2.
Jackson CE; Norum RA
Henry Ford Hosp Med J; 1989; 37(3-4):116-9. PubMed ID: 2576940
[TBL] [Abstract][Full Text] [Related]
18. Mapping of the genes around MEN2A locus using pulsed-field gel electrophoresis.
Tanaka N; Miki T; Yamamoto M; Nakura J; Okazaki M; Miya A; Mori T; Takai S
Jinrui Idengaku Zasshi; 1990 Dec; 35(4):325-30. PubMed ID: 1982737
[TBL] [Abstract][Full Text] [Related]
19. A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10.
Mathew CG; Chin KS; Easton DF; Thorpe K; Carter C; Liou GI; Fong SL; Bridges CD; Haak H; Kruseman AC
Nature; 1987 Aug 6-12; 328(6130):527-8. PubMed ID: 2886917
[TBL] [Abstract][Full Text] [Related]
20. Allele loss on chromosome 10 and point mutation of ras oncogenes are infrequent in tumors of MEN 2A.
Okazaki M; Miya A; Tanaka N; Miki T; Yamamoto M; Motomura K; Miyauchi A; Mori T; Takai S
Henry Ford Hosp Med J; 1989; 37(3-4):112-5. PubMed ID: 2576939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
